Acute Myeloid Leukemia Measurable Residual Disease

Alphabetical Test listing

Acute Myeloid Leukemia Measurable Residual Disease-12420

  
Acute Myeloid Leukemia Measurable Residual Disease
  
12420
  
LAB12420
  
PATR
  
AML MRD
Acute Leukemia
AML
Blast
Flow Cytometry
Residual AML
  
Tubes: M1, M2, M3, M4
Markers: CD2, CD5, CD7, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45, CD45RA, CD56, CD64, CD65, CD71, CD117, CD123, CD235a, CD300e, CD371, HLA-DR
  

Residual disease monitoring for patients with acute myeloid leukemia (AML)

  

Pathology orders only

  
First-pull Sodium Heparin Bone Marrow Aspirate
  

Sodium heparinized (Na hep) syringe

  
3 mL
  
1 mL
  
  • Collect 3 mL (minimum 1 mL) in a sodium heparinized (Na hep) syringe; transfer to an anticoagulant free sterile tube
  • Specimens collected in EDTA are acceptable, but not preferred
  

Do not spin

  

Anticoagulant free sterile tube

  
Bone marrow core
  
  

Refrigerate

  

Original container.  Keep refrigerated.

  

Sodium Heparin or EDTA Bone Marrow

Ambient

 

RPMI Bone Marrow Core

Refrigerated

  
14 days
  
  • Improper label (unlabeled or mislabeled)
  • Wrong container (anticoagulant or solution)
    • Bone marrow cores submitted in saline or B+ fixative are not acceptable and will be rejected
  • Delay in transport
  • Improper storage
  • Interfering substances
  • Leaking container
  
AHL - Flow Cytometry: F
  
Mo - Fr
  
2 days
  

Flow cytometry

  

Tubes and Markers:

Tubes:

M1, M2, M3, M4

Markers:

CD2, CD5, CD7, CD10, CD11b, CD13, CD14, CD15, CD16, CD19, CD33, CD34, CD36, CD38, CD45, CD45RA, CD56, CD64, CD65, CD71, CD117, CD123, CD235a, CD300e, CD371, HLA-DR

  
88184
88185 x 25
  
06/18/2024